| scholarly article | Q13442814 |
| P2093 | author name string | Cheon J | |
| Ko YH | |||
| Kim JJ | |||
| Moon DG | |||
| Park HS | |||
| Cho HY | |||
| Bae JH | |||
| P2860 | cites work | In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial. | Q33328885 |
| Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase gene | Q33943097 | ||
| In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy | Q34341355 | ||
| Human prostate-specific antigen: structural and functional similarity with serine proteases | Q35604260 | ||
| In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectors | Q41019039 | ||
| Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer | Q41275954 | ||
| Transcriptionally regulated adenoviruses for prostate-specific gene therapy | Q44522278 | ||
| Enhancement of the herpes simplex virus thymidine kinase/ganciclovir bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctions | Q45752639 | ||
| Retinoids augment the bystander effect in vitro and in vivo in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy | Q45759836 | ||
| Delayed morbidity and mortality of albumin/SV40 T-antigen transgenic mice after insertion of an alpha-fetoprotein/herpes virus thymidine kinase transgene and treatment with ganciclovir | Q45789886 | ||
| Delivery of adenoviral vectors to the prostate for gene therapy | Q45856917 | ||
| In vivo expression of prostate-specific adenoviral vectors in a canine model | Q45862635 | ||
| Methods for construction of adenovirus vectors | Q45866700 | ||
| Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients | Q46257091 | ||
| Cancer statistics, 1996. | Q50610104 | ||
| Age-related Changes in the Prostate and Testes of the Beagle Dog | Q54387024 | ||
| The prevalence of prostatism: a population-based survey of urinary symptoms | Q57540630 | ||
| Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors | Q68701451 | ||
| Adenocarcinoma of the canine prostate: immunohistochemical examination for secretory antigens | Q69008794 | ||
| Results of an epidemiological survey using a modified American Urological Association symptom index for benign prostatic hyperplasia in France | Q71619085 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | suicide | Q10737 |
| gene therapy | Q213901 | ||
| P304 | page(s) | 1129-1134 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | In vivo characterization of a prostate-specific antigen promoter-based suicide gene therapy for the treatment of benign prostatic hyperplasia | |
| P478 | volume | 10 |
| Q39566573 | Effect of electroporation-mediated diphtheria toxin A expression on PSA positive human prostate xenograft tumors in SCID mice |
| Q39942987 | Enhanced combined tumor-specific oncolysis and suicide gene therapy for prostate cancer using M6 promoter |
| Q36534930 | Frontiers in Suicide Gene Therapy of Cancer |
| Q33556564 | Safety and efficacy of suicide gene therapy with adenosine deaminase 5-fluorocytosine silmutaneously in in vitro cultures of melanoma and retinal cell lines |
| Q37347017 | Suicide Gene Therapy for Cancer - Current Strategies |
| Q35861497 | The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers |
| Q40409415 | Vector-based RNA interference against vascular endothelial growth factor-A significantly limits vascularization and growth of prostate cancer in vivo |
Search more.